General Information of the Compound
| Compound ID |
CP0415926
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(5,6-dimethoxypyridin-2-yl)methyl]-5-(1-methylpyrazol-4-yl)-2-(5-methylpyridin-3-yl)pyridine-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H24N6O3
|
||||||||||||||||||
| Molecular Weight |
444.495
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(CNC(=O)c2cc(ncc2-c2cnn(C)c2)-c2cncc(C)c2)nc1OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H24N6O3/c1-15-7-16(10-25-9-15)21-8-19(20(13-26-21)17-11-28-30(2)14-17)23(31)27-12-18-5-6-22(32-3)24(29-18)33-4/h5-11,13-14H,12H2,1-4H3,(H,27,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NEZSNFBWSKANAD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1